When Dr. Deborah Mash met the grandfather of ibogaine treatment, Howard Lotsof, and observed first-hand the effectiveness that ibogaine had for addiction interruption, she knew she’d found something special. Within a relatively short period of time, she petitioned for and received FDA approval to begin studying ibogaine within the US but soon ran into funding issues for the very costly research process.

Read full article: https://psychedelictimes.com/dr-deborah-mash-on-why-ibogaine-treatment-aftercare-is-key-to-treating-the-roots-of-addiction/